Request for Information (RFI): MDEpiNET PPP

Post Date

December 18th 2012

Application Due Date

January 11th 2013

Responses to this RFI are due January 11, 2013 by 11:59 PM Eastern Time. Responses must be submitted electronically to Lisa.Ko@fda.hhs.gov.

Funding Opportunity Number

NOT-FD-13-001

CFDA Number(s)

93.103

Funding Instrument Type(s)

Other

Funding Activity Categories

Consumer Protection
Health
Science and Technology and other Research and Development

Eligibility Categories

Unrestricted

Funding

• Award Range:

  $0 - $0

Grant Description

FDA is interested in obtaining multi stakeholder input related to the operations of the MDEpiNet PPP, to ensure that it is developed in a way that supports not only FDA, but the missions of other participating partners, thus providing the maximum impact on public health. This RFI is focused on better understanding of capabilities and approaches for the management of the MDEpiNet PPP to support the national postmarket surveillance plan. Specifically, FDA requires input related to the following questions: What role is envisioned for partners representing the patient, government, medical device industry, academia, health care providers, professional organizations, health care payer, and other sectors, and what are the parameters for their membership in the MDEpiNet PPP? Which additional partnership sectors should be represented, if any, and are there specific groups without whom the MDEpiNet PPP would not meet its mission? How would governance balance the desire for a comprehensive representative body against the need for nimble operations, usually accomplished through a small empowered team? What financial model(s) would best support the startup and sustained management of the PPP through the partnership management center? What are the ideal project proposal, selection, funding, and management models that would allow for appropriate buy-in and coordination, while allowing for scientific independence of investigators? What is the projected annual cost of operations, and what would be the ideal breakdown of federal and private funding to meet those needs?

Contact Information

• Agency

  Department of Health and Human Services

• Office:

  Food and Drug Administration

• Agency Contact:

  Lisa Ko
  Grants Management Specialist
  

• Agency Mailing Address:

  lisa.ko@fda.hhs.gov

• Agency Email Address:

  lisa.ko@fda.hhs.gov

• More Information:

  Link to Full Announcement on NIH Guide for Contracts and Grants